Clinical trial
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- July 31, 2011
- Enrollment
- 384 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.